MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 98 filers reported holding MAGENTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $23,161 | -4.6% | 30,555 | 0.0% | 0.00% | – |
Q1 2023 | $24,282 | +101.2% | 30,555 | 0.0% | 0.00% | – |
Q4 2022 | $12,069 | -71.9% | 30,555 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $43,000 | +16.2% | 30,555 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $37,000 | -58.4% | 30,555 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $89,000 | -34.1% | 30,555 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $135,000 | -39.2% | 30,555 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $222,000 | -24.2% | 30,555 | +1.8% | 0.00% | -33.3% |
Q2 2021 | $293,000 | -17.5% | 30,000 | 0.0% | 0.01% | -14.3% |
Q1 2021 | $355,000 | +51.1% | 30,000 | 0.0% | 0.01% | +40.0% |
Q4 2020 | $235,000 | +15.2% | 30,000 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $204,000 | -9.3% | 30,000 | 0.0% | 0.01% | -16.7% |
Q2 2020 | $225,000 | +43.3% | 30,000 | +20.0% | 0.01% | +20.0% |
Q1 2020 | $157,000 | -30.8% | 25,000 | +66.7% | 0.01% | 0.0% |
Q4 2019 | $227,000 | +47.4% | 15,000 | 0.0% | 0.01% | +25.0% |
Q3 2019 | $154,000 | -30.3% | 15,000 | 0.0% | 0.00% | -33.3% |
Q2 2019 | $221,000 | – | 15,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 6,758,204 | $19,599,000 | 7.18% |
TCG Crossover Management, LLC | 2,124,122 | $6,160,000 | 2.47% |
Atlas Venture Life Science Advisors, LLC | 3,476,536 | $10,082,000 | 1.28% |
Deep Track Capital, LP | 5,359,000 | $15,541,000 | 1.00% |
GREAT POINT PARTNERS LLC | 1,170,000 | $3,393,000 | 0.82% |
Casdin Capital, LLC | 2,773,468 | $8,043,000 | 0.36% |
Alphabet Inc. | 3,339,138 | $9,684,000 | 0.31% |
Bleichroeder LP | 484,400 | $1,405,000 | 0.25% |
HARBOR CAPITAL ADVISORS, INC. | 151,599 | $440,000 | 0.21% |
Integral Health Asset Management, LLC | 201,000 | $583,000 | 0.15% |